REQUEST A DEMO
Total
USD $0.00
Search more companies

Ilyang Pharm Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ilyang Pharm Co.,Ltd. Profile Updated: August 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Ilyang Pharmaceutical Co.,Ltd is a pharmaceutical company that offers a range of medicines and is focused on continuous research and development for new medicines. Ilyang has advanced factories and all production lines are furnished with KGMP and BGMP.

Headquarters
182-4 Hagal-Dong, Giheung-Gu, Yongin-Si
Yongin; Gyeonggi; Postal Code: 446-726

Contact Details: Purchase the Ilyang Pharm Co.,Ltd. report to view the information.

Website: http://www.ilyang.co.kr

Basic Information
Total Employees:
Purchase the Ilyang Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Ilyang Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Ilyang Pharm Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Ilyang Pharm Co.,Ltd. report to view the information.
Incorporation Date:
July 01, 1946
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
22.72%
Purchase this report to view the information.
4.04%
Purchase this report to view the information.
0.45%
Purchase this report to view the information.
0.4%
Purchase this report to view the information.
0.05%
Subsidiaries
양주일양제약유한공사
일양바이오팜
일양한중(상해)무역유한공사
Company Performance
Financial values in the chart are available after Ilyang Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-3.46%
Total operating revenue
-7.95%
Operating profit (EBIT)
-82.79%
EBITDA
-57.1%
Net Profit (Loss) for the Period
-99.65%
Total assets
-7.77%
Total equity
-9.88%
Operating Profit Margin (ROS)
-9.21%
Net Profit Margin
-8.24%
Return on Equity (ROE)
-10.84%
Debt to Equity Ratio
3.37%
Quick Ratio
-0.19%
Cash Ratio
-0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?